Cancer Monoclonal Antibodies Market 2017 Trends, Growth and Forecast to 2021
ReportsWeb.com published “Cancer Monoclonal Antibodies Market” from its database. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
(EMAILWIRE.COM, February 02, 2017 ) The mAbs, which are produced by genetic engineering, target antigens in cells, tissues, and organs. They are used in clinical applications to treat diseases with excellent efficacy and minimal side effects. Their MOA, absence of generic pathway, and therapeutic applications distinguish them from other targeted therapeutics.
Publisher's analysts forecast the global cancer monoclonal antibodies market to grow at a CAGR of 10.86% during the period 2017-2021.
For more information about this report: http://www.reportsweb.com/global-cancer-monoclonal-antibodies-market-2017-2021 .
Covered in this report
The report covers the present scenario and the growth prospects of the global cancer monoclonal antibodies market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of branded cancer mAbs and biosimilars used to treat cancer. It also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the patent expiries of the marketed drugs during the forecast period.
The market is divided into the following segments based on geography:
-Americas
-APAC
-EMEA
Publisher's report, Global Cancer Monoclonal Antibodies Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
-F. Hoffmann-La Roche
-Amgen
-Bristol-Myers Squibb
-Takeda Pharmaceuticals
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001522844/sample .
Other prominent vendors
-AbbVie
-ADC Therapeutics
-Agensys
-Argos Therapeutics
-Astellas Pharma
-AstraZeneca
-Bayer
-Biogen
-Biotech Pharmaceutical
-BioGenomics
-Boehringer Ingelheim
-Celldex Therapeutics
-Chugai Pharmaceutical
-CTI BioPharma
-Daiichi Sankyo
-Eli Lilly
-Fortress Biotech
-Genmab
-Immunomedics
-Intas Pharmaceuticals
-Janssen Biotech
-Kyowa Hakko Kirin
-Merck
-MedImmune
-Morphotek
-Neovii Biotech
-Novartis
-OncoMed Pharmaceuticals
-Pfizer
-Sanofi
-Seattle Genetics
-TG Therapeutics
-Xbiotech
Inquire for Report at http://www.reportsweb.com/inquiry&RW0001522844/buying .
Publisher's analysts forecast the global cancer monoclonal antibodies market to grow at a CAGR of 10.86% during the period 2017-2021.
For more information about this report: http://www.reportsweb.com/global-cancer-monoclonal-antibodies-market-2017-2021 .
Covered in this report
The report covers the present scenario and the growth prospects of the global cancer monoclonal antibodies market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of branded cancer mAbs and biosimilars used to treat cancer. It also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the patent expiries of the marketed drugs during the forecast period.
The market is divided into the following segments based on geography:
-Americas
-APAC
-EMEA
Publisher's report, Global Cancer Monoclonal Antibodies Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
-F. Hoffmann-La Roche
-Amgen
-Bristol-Myers Squibb
-Takeda Pharmaceuticals
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001522844/sample .
Other prominent vendors
-AbbVie
-ADC Therapeutics
-Agensys
-Argos Therapeutics
-Astellas Pharma
-AstraZeneca
-Bayer
-Biogen
-Biotech Pharmaceutical
-BioGenomics
-Boehringer Ingelheim
-Celldex Therapeutics
-Chugai Pharmaceutical
-CTI BioPharma
-Daiichi Sankyo
-Eli Lilly
-Fortress Biotech
-Genmab
-Immunomedics
-Intas Pharmaceuticals
-Janssen Biotech
-Kyowa Hakko Kirin
-Merck
-MedImmune
-Morphotek
-Neovii Biotech
-Novartis
-OncoMed Pharmaceuticals
-Pfizer
-Sanofi
-Seattle Genetics
-TG Therapeutics
-Xbiotech
Inquire for Report at http://www.reportsweb.com/inquiry&RW0001522844/buying .
Contact Information:
ReportsWeb.com
Priya Sisodia
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsWeb.com
Priya Sisodia
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results